Joseph Semien, MD
Obstetrics & Gynecology · Lake Charles, LANPI 1578793667
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (50.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Intuitive Surgical at 41.8% of the total. Among obstetrics & gynecology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 123 payments — averaging $90.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Boston Scientific$4K
- Sanara Medtech Inc.$558
- Coopersurgical, Inc.$277
- AbbVie$247
- Mayne Pharma Commercial LLC$203
- plus $1K from 16 others
What the payments were for
- Travel & lodging$5,54150%
- Food & beverage$4,04736%
- Education$1,50014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 19 | $4,640 |
| Boston Scientific | 25 | $4,124 |
| Sanara Medtech Inc. | 6 | $558 |
| Coopersurgical, Inc. | 5 | $277 |
| AbbVie | 12 | $247 |
| Mayne Pharma Commercial LLC | 6 | $203 |
| Evofem Biosciences, Inc. | 12 | $195 |
| Astellas Pharma US Inc | 8 | $149 |
| Hologic Sales And Service, LLC | 6 | $126 |
| Johnson & Johnson | 3 | $115 |
| Axonics, Inc. | 1 | $90 |
| Sumitomo Pharma America, Inc. | 3 | $70 |
| Merck | 4 | $66 |
| Pacira Pharmaceuticals Incorporated | 2 | $50 |
| Sage Therapeutics, LLC | 2 | $36 |
| Therapeuticsmd, Inc. | 2 | $30 |
| Pfizer | 2 | $27 |
| Coloplast | 1 | $21 |
| Organon | 1 | $20 |
| Millicent US Inc | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Lupin Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,017
- Solyx SIS System$1,740
- DAVINCI XI$1,500
- CAPIO$536
- ADVANTAGE FIT$516
- CellerateRx$414
- GENERAL FEMALE SUI$336
- UPSYLON$216
- ALLY II UPS$139
- Cook$139
How this compares
$11,088 in reported general payments places this provider in the 95th percentile of 608 obstetrics & gynecology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 40 | $26,397 |
| VeozahFezolinetant | 11 | $5,826 |
| Estradiol | 28 | $315 |
| Medroxyprogesterone Acetate | 20 | $258 |
| Tolterodine Tartrate ErTolterodine Tartrate | 12 | $252 |
| Clobetasol Propionate | 13 | $163 |
| Acyclovir | 17 | $119 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $105 |
| Fluconazole | 19 | $52 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq, Veozah | $149 | $32,22351 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 608 obstetrics & gynecology providers in Louisiana.
Other obstetrics & gynecology in Lake Charles
- Alice BabstLake Charles$8K
- James BrownLake Charles$6K
- Veronica GillispieNew Orleans$117K
- Rachel Bezdekla Place$105K
- Earl PeeperNew Orleans$95K
- Thomas PayneBaton Rouge$84K
- Catherine VanderloosShreveport$55K
- George MorrisNew Orleans$34K
- Russell PhelpsLafayette$31K
- Rachelle MeauxLafayette$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.